Michael Bell

Rational Vaccines, Inc. engages in the provision of vaccines in treating herpes and other chronic diseases. Its products include TheravaxHSV, a therapeutic vaccine that reduce the symptoms of herpetic disease and likelihood of spread and ProfavaxHSV, a prophylactic vaccination series that offers the opportunity for recipients to acquire protective immunity against HSV-1 or HSV-2. The company was founded by William Halford and Agustin Fernandez III in 2015 and is headquartered in Cambridge, MA.

Rational Vaccines, Inc. engages in the provision of vaccines in treating herpes and other chronic diseases. Its products include TheravaxHSV, a therapeutic vaccine that reduce the symptoms of herpetic disease and likelihood of spread and ProfavaxHSV, a prophylactic vaccination series that offers the opportunity for recipients to acquire protective immunity against HSV-1 or HSV-2. The company was founded by William Halford and Agustin Fernandez III in 2015 and is headquartered in Cambridge, MA.

Rational Vaccines, Inc. engages in the provision of vaccines in treating herpes and other chronic diseases. Its products include TheravaxHSV, a therapeutic vaccine that reduce the symptoms of herpetic disease and likelihood of spread and ProfavaxHSV, a prophylactic vaccination series that offers the opportunity for recipients to acquire protective immunity against HSV-1 or HSV-2. The company was founded by William Halford and Agustin Fernandez III in 2015 and is headquartered in Cambridge, MA.

Rational Vaccines, Inc. engages in the provision of vaccines in treating herpes and other chronic diseases. Its products include TheravaxHSV, a therapeutic vaccine that reduce the symptoms of herpetic disease and likelihood of spread and ProfavaxHSV, a prophylactic vaccination series that offers the opportunity for recipients to acquire protective immunity against HSV-1 or HSV-2. The company was founded by William Halford and Agustin Fernandez III in 2015 and is headquartered in Cambridge, MA.

Rational Vaccines, Inc. engages in the provision of vaccines in treating herpes and other chronic diseases. Its products include TheravaxHSV, a therapeutic vaccine that reduce the symptoms of herpetic disease and likelihood of spread and ProfavaxHSV, a prophylactic vaccination series that offers the opportunity for recipients to acquire protective immunity against HSV-1 or HSV-2. The company was founded by William Halford and Agustin Fernandez III in 2015 and is headquartered in Cambridge, MA.